DAA928 |
Sex hormone binding globulin levels increase |
Physiological |
plasma |
Human |
— |
— |
|
DAA919 |
Somatostatin basal levels increase |
Physiological |
plasma |
Human |
SST |
— |
|
DAA2432 |
sperm associated antigen 7 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SPAG7 |
26.2% Decrease DNA Methylation |
|
DAA2438 |
syncoilin; intermediate filament 1 increases with age |
Molecular |
mesenchymal stem cell |
Human |
SYNC |
21.4% Increase DNA Methylation |
|
DAA673 |
telomere length in hematopoietic stem cells |
Molecular |
hematopoietic stem cells |
Human |
— |
— |
|
DAA946 |
Thymic hormone levels decrease |
Physiological |
plasma |
Human |
— |
— |
|
DAA2459 |
transmembrane 4 superfamily member 3 increases with age |
Molecular |
mesenchymal stem cell |
Human |
TSPAN8 |
36.4% Increase DNA Methylation |
|
DAA699 |
Triglyceride levels increase |
Physiological |
plasma |
Human |
— |
— |
|
DAA2457 |
tumor necrosis factor receptor superfamily; member 17 increases with age |
Molecular |
mesenchymal stem cell |
Human |
TNFRSF17 |
18.8% Increase DNA Methylation |
|
DAA936 |
Volume of hematopoietic bone marrow decreases |
Physiological |
bone marrow |
Human |
— |
— |
|
DAA2440 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
Molecular |
mesenchymal stem cell |
Human |
WISP2 |
23.5% Decrease DNA Methylation |
|
DAA2435 |
zinc finger protein 549 increases with age |
Molecular |
mesenchymal stem cell |
Human |
ZNF549 |
19.3% Increase DNA Methylation |
|
DAA2611 |
miR-320b increases with age |
Molecular |
blood |
Human |
MIR320B1 |
1049.9% Increase miRNA Level |
|
DAA912 |
Aldosterone secretion, blood levels and clearance decrease |
Physiological |
plasma, adrenal gland |
Human |
— |
— |
|
DAA2035 |
Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA2443 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
15.1% Decrease DNA Methylation |
|
DAA2444 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
20.1% Decrease DNA Methylation |
|
DAA612 |
Anemia |
Pathological |
blood |
Human |
— |
SeriesMorbidity |
|
DAA2442 |
ATP-binding cassette; sub-family A member 8 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
ABCA8 |
25.0% Decrease DNA Methylation |
|
DAA675 |
Beta-galactosidase expression increases in mesenchymal stem cells |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA696 |
Blood cholesterol increases |
Physiological |
plasma |
Human |
— |
— |
|
DAA1210 |
blood CRP level increase |
Molecular |
plasma |
Human |
CRP |
— |
|
DAA1211 |
blood HSP70 level increase |
Molecular |
plasma |
Human |
— |
— |
|
DAA1209 |
Blood IL6 level increase |
Physiological |
plasma |
Human |
IL6 |
— |
|
DAA2017 |
Blood sugar changes |
Physiological |
plasma |
Human |
— |
— |
|